江苏吴中医药发展股份有限公司关于公司股票可能存在因股价低于1元而终止上市的风险提示公告

Core Viewpoint - Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. faces the risk of stock delisting due to its share price falling below 1 RMB, with a closing price of 0.95 RMB on September 9, 2025 [1][2] Group 1: Reasons for Potential Delisting - The company's stock may be delisted if it remains below 1 RMB for 20 consecutive trading days, as per the Shanghai Stock Exchange listing rules [2][3] - The stock's closing price on September 9, 2025, was 0.95 RMB, indicating a risk of delisting if the price does not recover [2] Group 2: Disclosure of Delisting Risk - The company is required to disclose the risk of delisting on the next trading day after its stock first closes below 1 RMB, and subsequently every trading day if the price remains below this threshold [3] - If the stock price remains below 1 RMB for 10 consecutive trading days, the company must continue to disclose this risk until the situation is resolved or delisting occurs [3] Group 3: Major Legal Violations and Delisting Risk - On July 13, 2025, the company received a notice from the China Securities Regulatory Commission regarding administrative penalties for inflating revenue, costs, and profits, which constitutes a major violation that could lead to forced delisting [4] - The company’s stock has been under a delisting risk warning since July 14, 2025, and may face delisting if the regulatory findings are confirmed [4]